Masimo News: Recent Developments and Product Launches

Masimo has been making waves in the medical technology industry with their innovative products and solutions. Their latest offerings have been designed to improve patient care and outcomes.

One notable development is the launch of the Masimo Patient SafetyNet, a remote monitoring system that enables continuous patient monitoring. This system is designed to help reduce hospital readmissions and improve patient safety.

The Masimo Radical-7 Pulse Oximeter has also been a game-changer in the industry, providing accurate and reliable pulse oximetry readings. Its advanced technology has made it a popular choice among healthcare professionals.

Masimo's commitment to innovation and patient care is evident in their product launches, which are designed to address specific needs and challenges in the healthcare industry.

Curious to learn more? Check out: Change Healthcare Free Credit Monitoring

Masimo has announced its financial results for various quarters, with the first quarter of 2013 seeing a total revenue of $214.7 million.

Masimo's financial results have been reported for the second quarter of 2012, with a total revenue of $235.8 million. This revenue figure is significantly higher than the first quarter of 2012, which had a total revenue of $211.3 million.

Related reading: What Happened with Apple Watch Masimo Lawsuit

Masimo's financial reporting is typically done on a quarterly basis, with the first quarter of 2012 seeing a revenue of $211.3 million. This revenue figure is a good indicator of the company's financial health.

Masimo has also signed a three-year, dual-source agreement with Novation, a healthcare contracting services company. This agreement is expected to have a significant impact on Masimo's revenue in the coming years.

If this caught your attention, see: Masimo Shares

Masimo has had a significant presence in the news lately. The company has been making progress in the treatment of PAD lesions, despite its BD stock being down.

Masimo's stock value has been a topic of discussion among investors. According to Yahoo Finance, the company's valuation is in focus as shares extend their recent decline.

The company is set to host an Investor Day on December 3, 2025. This event is expected to provide valuable insights into Masimo's future plans and strategies.

Masimo's financial performance has been a subject of interest among analysts. According to Yahoo Finance, upward analyst revisions and earnings optimism may reshape the company's investment narrative.

For another approach, see: Masimo Earnings

Masimo has been in the news for its real-world trial data for Masimo SET. The company has highlighted the effectiveness of this technology in various medical applications.

Masimo's stock value has fluctuated over the years. According to Benzinga, if you had invested $100 in Masimo 10 years ago, it would be worth a significant amount today.

Here are some key dates related to Masimo's news:

Masimo is hosting an Investor Day meeting for institutional investors and analysts on Thursday, September 20. This event will provide a platform for Masimo's management to share their insights and strategies with the investment community.

Masimo's Investor Day meeting is scheduled to take place on September 20, giving investors a chance to learn more about the company's plans and prospects.

Here's an interesting read: Meeting of the Minds

Masimo has successfully deployed its Patient SafetyNet with rainbow at Alameda County Medical Center, a significant step towards improving patient safety.

Readers also liked: Patient Capital

The deployment was announced on October 25, 2012, and marks a milestone in Masimo's efforts to provide innovative solutions to healthcare providers.

Masimo has also received U.S. FDA 510(k) clearance for its Signal Extraction Technology pulse oximeters, a significant regulatory approval that opens up new markets for the company.

This clearance is a testament to Masimo's commitment to developing high-quality medical devices that meet the highest standards of safety and effectiveness.

Masimo announced the launch of Root, a new product.

The company made this announcement at the European Society of Anesthesiology conference on June 5, 2013.

Masimo's product, Root, received CE Mark certification, allowing for international launch.

The University of North Carolina Hospitals in Chapel Hill ranked nationally in three adult and 10 pediatric specialties in 2013.

Suggestion: Enterprise and Regulatory Reform Act 2013

The Alameda County Medical Center (ACMC) has implemented Masimo Patient SafetyNet with rainbow, a technology that aims to improve patient safety. This deployment was announced on October 25, 2012.

The installation of Masimo Patient SafetyNet with rainbow at ACMC was a significant milestone for patient care. Masimo, a company that specializes in patient monitoring and noninvasive monitoring technologies, played a key role in this implementation.

This technology allows for the monitoring of various vital signs, including pulse rate, oxygen saturation, and hemoglobin levels. Noninvasive hemoglobin monitoring is a feature of the Pronto-7 handheld device, which was also developed by Masimo.

Masimo's Patient SafetyNet with rainbow has been successfully integrated into the ACMC's patient care system, providing healthcare professionals with real-time data to make informed decisions.

Intriguing read: African Rainbow Minerals

Masimo is suing US Customs and Border Protection (CBP) over the agency's decision to allow Apple to restore the blood oxygen tracking feature on Apple Watches.

Apple has been embroiled in legal disputes over Masimo's blood oxygen sensor patent since 2020, following an ITC import ban in December 2023.

Curious to learn more? Check out: Black Oxygen Organics

Masimo Corp., a medical device maker, is dealing with a cyberattack that's impacted its ability to fulfill orders.

The attack was discovered on April 27 and has temporarily interfered with Masimo's ability to process, fulfill, and ship customer orders in a timely manner.

Masimo immediately took steps to contain the incident and isolate the affected systems, and is working with third-party incident response experts to assess, mitigate, and remediate the attack.

Law-enforcement authorities have been notified, and the company is coordinating its response with them.

The incident has disrupted Masimo's website and several of its computer systems, but CEO Katie Szyman says it won't change the company's financial guidance.

Masimo's filing with the SEC cautions that the full scope, nature, and impact of the incident are still being determined.

Expand your knowledge: Dusting Attack

Masimo is suing US Customs and Border Protection over Apple Watch imports. They claim Customs helped Apple create a loophole in the ITC's patent ruling.

Apple has been in a legal dispute with Masimo over the blood oxygen sensor patent since 2020. This led to a ban on importing Apple Watches with the feature.

Intriguing read: Patent

The ban was put in place by the International Trade Commission in December 2023. Apple disabled the feature on supported US Apple Watch models as a result.

Masimo only learned that the ban had been reversed after Apple announced a "redesigned" pulse oximetry feature. This feature calculates blood oxygen levels on iPhones instead of the Watch.

Masimo claims that Customs failed to notify them of the decision to reverse the ITC restrictions. They had no opportunity to review or challenge the ruling.

Additional reading: Canadian Currency Tactile Feature